
Keywords: اینترلوکین 6; IGF; insulin-like growth factor; IGFR1; IGF receptor-1; IGFBP; IGF binding proteins; IR; insulin resistance; MS; metabolic syndrome; TNF-α; tumor necrosis factor α; IL-6; interleukin 6; MCP-1; monocyte chemotactic protein-1; PAI-1; plasminogen activator